Rx Note

Introduction Polycystic ovary syndrome (PCOS) is a heterogenous disorder characterized by a combination of clinical and/or biochemical hyperandrogenism, ovulatory dysfunction and/or polycystic ovarian morphology. Additional features or associated conditions include obesity , hyperinsulinemia and infertility . Consider the possibility of PCOS in females presenting with menstrual disturbance, hirsutism or premenopausal alopecia . It is the most common endocrine disorder in women of reproductive age. Clinical Presentation Clinical presentation varies, with some women being asymptomatic and other women presenting with multiple dermatologic, glynaecologic and/or metabolic manifestations. Women with PCOS typically present with Clinical hyperandrogenism including hirsutism, acne and androgenetic alopecia . Ovulatory dysfunction including abnormal menses and infertility Obesity Management Therapy is individualized based on clinical presentation and patient goals, such as desire for pregnancy...

Introduction The rationale of contraception is to prevent an unintended pregnancy . According to 2011 data , about 45% of pregnancies are unintended in the United States, with about 42% of those resulting in abortions. NOTE: Contraception should generally be continued for 1 year after the last period if >50 years (for 2 years if <50). Contraceptive Methods There are many factors in selecting contraception. Effectiveness Importance of not being pregnant Likelihood and ability to adhere Frequency of intercourse Age Cost and ability to pay Adverse effects Perceptions, misperceptions, risk-benefit Concomitant drug use Health status and habits Patients' preference Women with comorbid medical conditions (e.g. thromboembolic disease, hypertension , diabetes , HIV infection, obesity , pelvic infection and seizure disorders) should be offered contraceptive methods in accordance with the WHO Medical Eligibility Criteria for Contraceptive Use or other relevant guidelines (e.g. The Un...